viloxazine/trazodone (AD816) / Apnimed - LARVOL DELTA

Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study. (PubMed, Thorax) - P2 | "Viloxazine-trazodone reduced OSA severity. Potential deleterious effects of viloxazine on sleep quality appeared partly attenuated by trazodone."

Journal • CNS Disorders • Constipation • Dental Disorders • Gastroenterology • Gastrointestinal Disorder • Insomnia • Obstructive Sleep Apnea • Pain • Respiratory Diseases • Sleep Apnea • Sleep Disorder • Xerostomia

VicTor: AD816 Crossover Study (clinicaltrials.gov) - P2 | N=25 | Completed | Sponsor: Apnimed | Active, not recruiting ➔ Completed

Trial completion • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder

VicTor: AD816 Crossover Study (clinicaltrials.gov) - P2 | N=25 | Active, not recruiting | Sponsor: Apnimed | Recruiting ➔ Active, not recruiting | Trial completion date: Aug 2023 ➔ Nov 2023 | Trial primary completion date: Aug 2023 ➔ Nov 2023

Enrollment closed • Trial completion date • Trial primary completion date • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder